SKI Market

Indian Indices

Nifty

26,205.30 320.50
(1.24%)

Sensex

85,609.51 1,022.50
( 1.21%)

Bank Nifty

59,528.05 707.75
( 1.20%)

Nifty IT

37,364.60 537.70
( 1.46%)

Global Indices

Nasdaq

47,129.48 660.20
(1.42%)

Dow Jones

6,786.30 60.18
(0.89%)

Hang Seng

49,532.43 872.91
(1.79%)

Nikkei 225

9,602.38 67.47
(0.71%)

Forex

USD-INR

89.21 -0.39
(-0.43%)

EUR-INR

102.81 -0.34
(-0.33%)

GBP-INR

116.86 -0.46
(-0.39%)

JPY-INR

0.57 0.00
(-0.65%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

39.04

770.97

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.23

Back

edvenswa enterprises ltd

Board of Balkrishna Industries recommends Second Interim Dividend

Oct 31,2025

Balkrishna Industries announced that the Board of Directors of the Company at its meeting held on 31 October 2025, has recommended a Second Interim Dividend of Rs.4 per share (i.e.200%), subject to the approval of the shareholders.

26,205.30 320.50 (1.24%)

85,609.51 1,022.50 ( 1.21%)

59,528.05 707.75 ( 1.20%)

37,364.60 537.70 ( 1.46%)

47,129.48 660.20 (1.42%)

6,786.30 60.18 (0.89%)

49,532.43 872.91 (1.79%)

9,602.38 67.47 (0.71%)

89.21 -0.39 (-0.43%)

102.81 -0.34 (-0.33%)

116.86 -0.46 (-0.39%)

0.57 0.00 (-0.65%)